Document is current

Any future updates will be listed below

First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action

Crossref DOI link: https://doi.org/10.1007/s00228-016-2077-2

Published Online: 2016-06-03

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark